Japanese drugmaker Takeda will present data on both its investigational and marketed assets at the upcoming annual meeting of the American Society of Clinical Oncology. 17 May 2019
Eli Lilly’s data at the American Society of Clinical Oncology annual meeting this year will provide results on its research in lung cancer. 16 May 2019
Seattle Genetics will present data from six of its programs at the American Society of Clinical Oncology (ASCO) annual meeting later this month. 16 May 2019
Eisai says it will provide data on Lenvima (lenvatinib mesylate ) and Halaven (eribulin mesylate) at this month’s annual meeting of the American Society of Clinical Oncology (ASCO). 16 May 2019
Hangzhou, the capital of east China's Zhejiang Province, has seen seven bio-pharmaceutical projects implemented in the first quarter of the year, with a total investment of 1.5 billion renminbi (~$220 million), according to the latest data from the Hangzhou Investment Promotion Bureau today. 15 May 2019
California-based Alphaeon Corp today announced today that it has named Marc Forth as president and chief executive of its newly-established, wholly-owned subsidiary, AEON Biopharma. 13 May 2019
Japan’s Takeda announced that it is divesting its TachoSil Fibrin Sealant Patch to Ethicon as part of its strategy to focus on business areas core to its long-term growth and facilitate rapid deleveraging following its acquisition of Shire. 9 May 2019
Sandoz, a Novartis Division, announces that its large wholesaler customers are now fully stocked to supply hospitals and clinics with Symjepi (epinephrine) 0.3mg Injection inventory in the USA for the emergency treatment of allergic reactions (Type 1), including anaphylaxis. 9 May 2019
The European Medicines Agency (EMA) has launched a social media campaign to highlight “the added value of European cooperation in keeping medicines safe,” from monitoring and analysis, to raising safety standards promoting patient reporting of issues. 7 May 2019
Israel’s RedHill Biopharma today announced that, following a positive pre-NDA meeting held recently with the US Food and Drug Administration, it has submitted a New Drug Application (NDA) to the FDA for Talicia (RHB-105) for the treatment of H. pylori infection. 7 May 2019
BioMarin Pharmaceutical has won European approval for Palynziq (pegvaliase injection) as a therapy for certain people with phenylketonuria (PKU). 7 May 2019
Neurocrine Biosciences has been buoyed by positive data from two Phase III studies of its Parkinson's disease candidate opicapone, presented at the annual meeting of the American Academy of Neurology (AAN). 7 May 2019
China’s WuXi AppTec has acquired Pharmapace, a USA-based clinical research services company with expertise of providing high quality biometrics services for all phases of clinical trials, regulatory submissions, and post marketing support. 7 May 2019
A new study in the Journal of General Internal Medicine has found that financial hardship associated with high medical costs is “very common among people in the United States.” 3 May 2019
The USA’s Institute for Clinical and Economic Review (ICER) has posted a Draft Scoping Document outlining a planned review of the comparative clinical effectiveness and value of oral semaglutide from Danish diabetes giant Novo Nordisk and other treatments for type 2 diabetes mellitus. 3 May 2019
Insys Therapeutics founder John Kapoor faces up to 20 years in prison after being convicted of bribing doctors to prescribe opioids in the USA. 3 May 2019
ViiV Healthcare, the specialist HIV company majority owned by GSK, today announced the presentation of new real-world evidence and implementation data showing the effectiveness, adherence, and quality-of-life improvement of Apretude (cabotegravir long-acting (CAB LA)) for HIV pre-exposure prophylaxis (PrEP). 16 October 2024
Jaguar Health today announced the US launch of Gelclair, the only Food and Drug Administration (FDA)-approved mucoadhesive on the market indicated for the management of pain caused by oral mucositis 16 October 2024
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
US pharma major Eli Lilly has announced a strategic collaboration with two UK government departments and the devolved nations to tackle significant population health challenges, including exploring new models to better care for people living with obesity. 16 October 2024
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Switzerland-based Novocure saw its shares rise 10% yesterday and leap a further 24% to $22.05 pre-market, after the company received a new US regulatory approval for its key product Optune Lua. 16 October 2024
Shares of Spanish drugmaker PharmaMar leapt more than 28% to 63.70 euros today, after it announced positive clinical trial findings for its combo lung cancer treatment, under development with USA-based Jazz Pharmaceuticals, which rose 4.2%. 15 October 2024
Novartis has discontinued an early Phase II trial of LTP001 in idiopathic pulmonary fibrosis (IPF). The company confirmed that the decision was not related to safety, with no issues emerging in the study. 15 October 2024
US pharma major Eli Lilly has announced plans to invest around 1.5 billion renminbi ($206 million) into expanding its manufacturing facility in Suzhou, China. 15 October 2024
Spanish dermatology specialist Almirall (BME: ALM) has announced the successful completion of the decentralized regulatory procedure in Europe for efinaconazole. 15 October 2024
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
India's Central Drugs Standard Control Organization (CDSCO) has provided a favorable recommendation for its novel antibiotic Miqnaf (nafithromycin) discovered and developed for the treatment of community-acquired bacterial pneumonia (CABP) in adults. 14 October 2024
The Danish Medicines Council (Medicinrådet), responsible for evaluating and recommending new treatments for Denmark’s healthcare system, is facing a significant increase in processing times. 14 October 2024
The South African Health Products Regulatory Authority (SAHPRA) and the Australian Therapeutic Goods Administration (TGA) have signed a Memorandum of Understanding (MoU), which will strengthen collaboration between the two health product regulators. 14 October 2024
California-based AI company Suki has raised $70 million in new funding to accelerate the growth of its AI-powered voice solutions in healthcare. 11 October 2024
Pfizer is to present initial findings from its CULTIVATE study of its sphingosine-1-phosphate (S1P) receptor modulator Velsipity (etrasimod) in Crohn’s disease (CD) at United European Gastroenterology Week 2024. 11 October 2024
Switzerland-based KeyBioscience and US pharma major Eli Lilly have agreed to extend their collaboration on the development of dual amylin calcitonin receptor agonists (DACRA), a new class of potential treatments for obesity and related disorders. 11 October 2024